{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:32:19Z","timestamp":1792017139418,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National High Technology Research and Development Program of China (863 Program)","award":["2007AA021802"],"award-info":[{"award-number":["2007AA021802"]}]},{"name":"Major Special Project from Ministry of Health of China","award":["201002010"],"award-info":[{"award-number":["201002010"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300629"],"award-info":[{"award-number":["81300629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.biomaterials.2013.09.027","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T03:35:19Z","timestamp":1379993719000},"page":"10258-10266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette\u2013Gu\u00e9rin in the treatment of bladder cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Dong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aibing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.09.027_bib1","first-page":"180","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to Bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/1750743X.1.2.281","article-title":"Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder","volume":"1","author":"Kresowik","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1517\/13543784.17.7.1067","article-title":"Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent","volume":"17","author":"Morales","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00262-009-0673-z","article-title":"Recombinant Bacillus Calmette-Guerin (BCG) expressing interferon-alpha 2b enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in\u00a0vitro","volume":"58","author":"Liu","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1023\/B:PHAM.0000026436.62869.9c","article-title":"Sustained intravesical drug delivery using thermosensitive hydrogel","volume":"21","author":"Tyagi","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ucl.2006.06.012","article-title":"Local drug delivery to bladder using technology innovations","volume":"33","author":"Tyagi","year":"2006","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jps.22328","article-title":"Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery","volume":"100","author":"Shi","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijbiomac.2012.11.026","article-title":"A\u00a0novel injectable temperature-sensitive zinc doped chitosan\/beta-glycerophosphate hydrogel for bone tissue engineering","volume":"54","author":"Niranjan","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929867311302010009","article-title":"Thermosensitive polymeric hydrogels as drug delivery systems","volume":"20","author":"Gong","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1080\/09205063.2013.789357","article-title":"A\u00a0novel chitosan-based thermosensitive hydrogel containing doxorubicin liposomes for topical cancer therapy","volume":"24","author":"Wang","year":"2013","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-003-0597-9","article-title":"Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers","volume":"51","author":"Leakakos","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib15","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.2147\/IJN.S35140","article-title":"Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells","volume":"7","author":"Chen","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib17","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1016\/j.actbio.2012.09.034","article-title":"Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin","volume":"9","author":"Peng","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1464-410X.2010.09326.x","article-title":"Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model","volume":"107","author":"Parada","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.18632\/oncotarget.852","article-title":"Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression","volume":"4","author":"Delto","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib20","first-page":"1867","article-title":"Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549\/DDP lung cancer cells in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Li","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib21","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/0008-5472.CAN-09-1114","article-title":"Intravesical immunotherapy of superficial bladder cancer with chitosan\/interleukin-12","volume":"69","author":"Zaharoff","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2008.01.013","article-title":"Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma","volume":"54","author":"Dovedi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2013.01.025","article-title":"C(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer","volume":"169","author":"Zhou","year":"2013","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2012.04.033","article-title":"Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia","volume":"161","author":"Hastings","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1080\/09205063.2013.789357","article-title":"A\u00a0novel chitosan-based thermosensitive hydrogel containing doxorubicin liposomes for topical cancer therapy","volume":"24","author":"Wang","year":"2013","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.biomaterials.2012.10.077","article-title":"Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer","volume":"34","author":"Bae","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib28","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10904.x","article-title":"The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer","volume":"110","author":"Richterstetter","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00262-007-0397-x","article-title":"The fibronectin attachment protein of Bacillus Calmette-Guerin (BCG) mediates antitumor activity","volume":"57","author":"Sinn","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(01)00979-6","article-title":"Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer","volume":"235","author":"Ero\u011flu","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib32","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.biomaterials.2011.12.034","article-title":"The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier","volume":"33","author":"Rosenthal","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib33","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.biomaterials.2009.03.013","article-title":"Influence of the degree of acetylation on the enzymatic degradation and in\u00a0vitro biological properties of trimethylated chitosans","volume":"30","author":"Verheul","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/vim.2012.0057","article-title":"Evaluation of the effectiveness and safety of chitosan derivatives as adjuvants for intranasal vaccines","volume":"26","author":"Kobayashi","year":"2013","journal-title":"Viral Immunol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00345-007-0198-z","article-title":"Study on enhancement of fibronectin-mediated Bacillus Calmette-Guerin attachment to urinary bladder wall in rabbits","volume":"25","author":"Shen","year":"2007","journal-title":"World J Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.urology.2007.11.080","article-title":"Low-dose instillation therapy with Bacille Calmette-Guerin Tokyo 172 strain after transurethral resection: historical cohort study","volume":"71","author":"Yoneyama","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.0919-8172.2003.00607.x","article-title":"Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose Bacillus Calmette-Guerin for superficial bladder cancer recurrence","volume":"10","author":"Irie","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical Bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Martinez-Pineiro","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2009.01.018","article-title":"Chitosan-dibasic orthophosphate hydrogel: a potential drug delivery system","volume":"371","author":"Ta","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.09.027_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch Pharm Res"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213011101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213011101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:53:43Z","timestamp":1758902023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213011101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":40,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0142961213011101"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.09.027","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette\u2013Gu\u00e9rin in the treatment of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}